Cell Therapy Manufacturing: Autologous VS Allogenic Strategies (Individual)

While related, scaling autologous and allogeneic cell therapies require vastly different manufacturing approaches, equipment, and technologies. Regardless of the platform chosen, implementing the right strategy early is the key to success. Our experts share their personal experiences and insight to help you anticipate challenges and implement better cell therapy strategies.

Register for Multiple EBP Events

Network, interact and share ideas with fellow bioprocessing leaders and decision-makers and gain access to applicable ideas on how to improve and accelerate your bioprocess. Access to on-demand event presentations, expert podcasts, event eBooks, and more.